Dr. Cora Sternberg presented the long term results of EORTC trial 30994 at ASCO 2014 in Chicago
4 Jun 2014
Dr. Cora N. Sternberg of the San Camillo and Forlanini Hospitals in Rome and study coordinator of EORTC trial 30994, presented the long term results of that trial at ASCO 2014 in Chicago. The results lend new support to use of immediate cisplatin-based chemotherapy following surgical resection. An overview of the trial results were reported in the 03 June 2014 ASCO Daily News.
Related News
EORTC presents new results in neuro-oncology at EANO
28 Sep 2026
EORTC BRACE study reaches key milestones with first patient enrolment
25 Sep 2026
In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group
7 Sep 2026
New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults
4 Sep 2026
New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors
25 Aug 2026
EORTC calls for a balanced and feasible European Health Data Space (EHDS)
8 Jul 2026
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
